Resolving cancer-stroma interfacial signalling and interventions with micropatterned tumour-stromal assays

Nature Communications

Volumn 5, Issue , 2014, Pages

  Shen, Keyue ^a   Luk, Samantha ^a   Hicks, Daniel F ^b   Elman, Jessica S ^a,e,f,g,h,i   Bohr, Stefan ^a   Iwamoto, Yoshiko ^b   Murray, Ryan ^a   Pena, Kristen ^c   Wang, Fangjing ^a   Seker, Erkin ^a   Weissleder, Ralph ^b   Yarmush, Martin L ^a   Toner, Mehmet ^a   Sgroi, Dennis ^b   Parekkadan, Biju ^a,d  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Massachusetts Institute of Technology   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g Department of Plastic Surgery RWTH University Clinics ^*  (United States)

^h ALLERGAN INC   (United States)

ⁱ University of California Davis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE 14; 2-(4-MORPHOLINOANILINO)-6-CYCLOHEXYLAMINOPURINE; COLLAGEN; GREEN FLUORESCENT PROTEIN; KI 67 ANTIGEN; MORPHOLINE DERIVATIVE; PURINE DERIVATIVE;

BIOASSAY; COLLAGEN; ESTROGENIC COMPOUND; GERM CELL; PHENOTYPE; SIGNALING; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BONE METASTASIS; BREAST CANCER; CANCER CELL; CELL COMPONENT; CELL CONTACT; CELL INFILTRATION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LASER CAPTURE MICRODISSECTION; MESENCHYMAL STROMA CELL; MICROPATTERNED TUMOR STROMAL ASSAY; MOUSE; NONHUMAN; PHENOTYPE; STROMA CELL; ANIMAL; BONE MARROW CELL; BONE TUMOR; BREAST TUMOR; CANCER TRANSPLANTATION; CHEMISTRY; DISEASE COURSE; EXPERIMENTAL MAMMARY NEOPLASM; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; METASTASIS; MICROCIRCULATION; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BONE MARROW CELLS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; COLLAGEN; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HUMANS; KI-67 ANTIGEN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED NOD; MICE, SCID; MICROCIRCULATION; MORPHOLINES; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PURINES; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 84923371522     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6662     Document Type: Article

References (70)

1. Sgroi, D. C. Preinvasive breast cancer. Annu. Rev. Pathol. 5, 193-221 (2010).
2. Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17-32 (2004).
3. Ma, X. J., Dahiya, S., Richardson, E., Erlander, M. & Sgroi, D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7 (2009).
4. De Wever, O. et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem. Cell Biol. 130, 481-494 (2008).
5. Gao, M. Q. et al. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J. Cell Sci. 123, 3507-3514 (2010).
6. Polyak, K. & Hu, M. Do myoepithelial cells hold the key for breast tumor progression? J. Mammary Gland Biol. Neoplasia 10, 231-247 (2005).
7. Casbas-Hernandez, P., Fleming, J. M. & Troester, M. A. Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. J. Biomed. Biotechnol. 2011, 520987 (2011).
8. McMillin, D. W. et al. Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat. Med. 16, 483-489 (2010).
9. Shvartsman, S. Y., Wiley, H. S., Deen, W. M. & Lauffenburger, D. A. Spatial range of autocrine signaling: modeling and computational analysis. Biophys. J. 81, 1854-1867 (2001).
10. Nelson, C. M. et al. Emergent patterns of growth controlled by multicellular form and mechanics. Proc. Natl Acad. Sci. USA 102, 11594-11599 (2005).
11. Hui, E. E. & Bhatia, S. N. Micromechanical control of cell-cell interactions. Proc. Natl Acad. Sci. USA 104, 5722-5726 (2007).
12. Bhatia, S. N., Balis, U. J., Yarmush, M. L. & Toner, M. Microfabrication of hepatocyte/fibroblast co-cultures: role of homotypic cell interactions. Biotechnol. Prog. 14, 378-387 (1998).
13. El-Ali, J., Sorger, P. K. & Jensen, K. F. Cells on chips. Nature 442, 403-411 (2006).
14. Lee, J. Y., Jones, C., Zern, M. A. & Revzin, A. Analysis of local tissue-specific gene expression in cellular micropatterns. Anal. Chem. 78, 8305-8312 (2006).
15. Folch, A. & Toner, M. Microengineering of cellular interactions. Annu. Rev. Biomed. Eng. 2, 227-256 (2000).
16. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).
17. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
18. Knupfer, H. & Preiss, R. Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res. Treat. 102, 129-135 (2007).
19. Flaberg, E. et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int. J. Cancer 128, 2793-2802 (2011).
20. DeCarlo, K., Emley, A., Dadzie, O. & Mahalingam, M. in: Laser Capture Microdissection. (ed Murray, G. I.) (Humana, 2011).
21. Mueller, M. M. & Fusenig, N. E. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839-849 (2004).
22. Bissell, M. J. & Hines, W. C. Why don't we get more cancer A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17, 320-329 (2011).
23. Bissell, M. J. & Radisky, D. Putting tumours in context. Nat. Rev. Cancer 1, 46-54 (2001).
24. Kojima, Y. et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc. Natl Acad. Sci. USA 107, 20009-20014 (2010).
25. Friedl, P. & Alexander, S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009 (2011).
26. Soini, Y. et al. Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer 11, 1-8 (2011).
27. Palmieri, C., Fullarton, J. R. & Brown, J. Comparative efficacy of bisphosphonates in metastatic breast and prostate cancer and multiple myeloma: a mixed-treatment meta-Analysis. Clin. Cancer Res. 19, 6863-6872 (2013).
28. Wang, X., Zhang, Z. & Yao, C. Bortezomib inhibits the angiogenesis mediated by mesenchymal stem cells. Cancer Invest. 30, 657-662 (2012).
29. Singh-Ranger, G., Salhab, M. & Mokbel, K. The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res. Treat. 109, 189-198 (2008).
30. Nemeth, K. et al. Characterization and function of histamine receptors in human bone marrow stromal cells. Stem Cells 30, 222-231 (2012).
31. Takada, I., Kouzmenko, A. P. & Kato, S. PPAR-gamma signaling crosstalk in mesenchymal stem cells. PPAR Res. 2010, 341671 (2010).
32. Peltz, L. et al. Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development. PLoS ONE 7, e37162 (2012).
33. Gupta, P. B. et al. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res. 67, 2062-2071 (2007).
34. Csiszar, K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70, 1-32 (2001).
35. Provenzano, P. et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6, 11 (2008).
36. Direkze, N. C. et al. Bone marrow contribution to tumor-Associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492-8495 (2004).
37. Sappino, A. P., Skalli, O., Jackson, B., Schurch, W. & Gabbiani, G. Smoothmuscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int. J. Cancer 41, 707-712 (1988).
38. Sgroi, D. C. Breast cancer Src activity: bad to the bone. Cancer Cell 16, 1-2 (2009).
39. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
40. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
41. Hu, M. et al. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc. Natl Acad. Sci. USA 106, 3372-3377 (2009).
42. Nakagawa, H. et al. Role of cancer-Associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23, 7366-7377 (2004).
43. Hansen, R. K. & Bissell, M. J. Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. Endocr. Relat. Cancer 7, 95-113 (2000).
44. Vidal, M. et al. A role for the epithelial microenvironment at tumor boundaries: evidence from drosophila and human squamous cell carcinomas. Am. J. Pathol. 176, 3007-3014 (2010).
45. Franci, C. et al. Expression of Snail protein in tumor-stroma interface. Oncogene 25, 5134-5144 (2006).
46. Chai, H. & Brown, R. E. Field effect in cancer-An update. Ann. Clin. Lab. Sci. 39, 331-337 (2009).
47. Leung, C. T. & Brugge, J. S. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature 482, 410-413 (2012).
48. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
49. Khetani, S. R. & Bhatia, S. N. Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26, 120-126 (2008).
50. Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-575 (2012).
51. Lapointe, J. et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA 101, 811-816 (2004).
52. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
53. Chang, H. Y. et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc. Natl Acad. Sci. USA 102, 3738-3743 (2005).
54. Downward, J. The ins and outs of signalling. Nature 411, 759-762 (2001).
55. Chen, S., Zhang, Q., Wu, X., Schultz, P. G. & Ding, S. Dedifferentiation of lineage-committed cells by a small molecule. J. Am. Chem. Soc. 126, 410-411 (2003).
56. Hsieh, T. C., Traganos, F., Darzynkiewicz, Z. & Wu, J. M. The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells. Int. J. Oncol. 31, 1293-1300 (2007).
57. D'Alise, A. M. et al. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Mol. Cancer Ther. 7, 1140-1149 (2008).
58. Kuo, C. H. et al. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells. Breast Cancer 21, 358-369 (2012).
59. Jemaa, M. et al. Preferential killing of p53-deficient cancer cells by reversine. Cell Cycle 11, 2149-2158 (2012).
60. Lee, Y. R. et al. Reversine suppresses oral squamous cell carcinoma via cell cycle arrest and concomitantly apoptosis and autophagy. J. Biomed. Sci. 19, 9 (2012).
61. Hua, S.-C. et al. Reversine, a 2,6-disubstituted purine, as an anti-cancer agent in differentiated and undifferentiated thyroid cancer cells. Pharm. Res. 29, 1990-2005 (2012).
62. Qin, H. X. et al. Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo. Cytotechnology 65, 643-653 (2013).
63. Wang, F. et al. Reciprocal interactions between b1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl Acad. Sci. USA 95, 14821-14826 (1998).
64. Debnath, J. & Brugge, J. S. Modelling glandular epithelial cancers in threedimensional cultures. Nat. Rev. Cancer 5, 675-688 (2005).
65. Pampaloni, F. & Reynaud, E. G. Stelzer EHK. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839-845 (2007).
66. Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 4, 309-324 (2009).
67. Love, Z. et al. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J. Nucl. Med. 48, 2011-2020 (2007).
68. Parekkadan, B. et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE 2, e941 (2007).
69. Silver, F. H. & Trelstad, R. L. Type I collagen in solution. Structure and properties of fibril fragments. J. Biol. Chem. 255, 9427-9433 (1980).
70. Armbruster, D. A. & Pry, T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 29 (Suppl 1), S49-S52 (2008).